HighMark Wealth Management’s Celularity CELU Stock Holding History

HighMark Wealth Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$586	Hold	441	–	–	﹤0.01%	504
2025 Q4	$489	Hold	441	–	–	﹤0.01%	541
2025 Q3	$913	Hold	441	–	–	﹤0.01%	532
2025 Q2	$864	Hold	441	–	–	﹤0.01%	533
2025 Q1	$763	Hold	441	–	–	﹤0.01%	502
2024 Q4	$917	Hold	441	–	–	﹤0.01%	498
2024 Q3	$1.31K	Hold	441	–	–	﹤0.01%	507
2024 Q2	$1.38K	Hold	441	–	–	﹤0.01%	492
2024 Q1	$2.31K	Sell	441 -1	-0.2%	-$4	﹤0.01%	460
2023 Q4	$1.09K	Sell	442 -330	-43%	-$717	﹤0.01%	504
2023 Q3	$1.71K	Hold	772	–	–	﹤0.01%	471
2023 Q2	$4.11K	Hold	772	–	–	﹤0.01%	383
2023 Q1	$4.78K	Hold	772	–	–	﹤0.01%	405
2022 Q4	$9.96K	Buy	772 +330	+75%	+$6.08K	0.01%	258
2022 Q3	$10K	Hold	442	–	–	0.01%	238
2022 Q2	$15K	Hold	442	–	–	0.01%	196
2022 Q1	$29K	Buy	+442	New	+$26.5K	0.02%	140

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

HighMark Wealth Management's CELU Position: Q1 2026 in Review

HighMark Wealth Management held its Celularity (CELU) position steady in Q1 2026 at 441 shares worth $586. The position accounts for ﹤0.01% of the portfolio, ranked #504.

HighMark Wealth Management first reported a position in CELU in Q1 2022 and has held it in 17 quarters since. The position peaked at $29K in Q1 2022. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

HighMark Wealth Management held 441 shares of Celularity worth $586 as of Q1 2026.
HighMark Wealth Management left its Celularity share count unchanged in Q1 2026.
Celularity made up ﹤0.01% of HighMark Wealth Management's portfolio in Q1 2026, its #504 holding.
HighMark Wealth Management first reported a position in Celularity in Q1 2022 and has held it in 17 quarters since.
HighMark Wealth Management's Celularity position peaked at $29K in Q1 2022.
38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.